Suchergebnisse - "Tanoglu, Alpaslan"

PubPharm (8)

1

Assessment and outcome of hospitalized patients during delta variant COVID-19 pandemic : A multicenter international study

enthalten in: Journal of infection in developing countries | 2022

von Amer, F. | Saeed, M. | Wagih Shaltout, S. | +9

2

RT- PCR testing of upper respiratory tract samples for diagnosis of SARS-CoV-2 : Between justification and overestimation, a multi-center international study

enthalten in: Travel medicine and infectious disease | 2022

von Hammad, N. | Saeed, M. | Shaltout, S. | +9

3

Use of the derived isohemagglutinin parameter to predict patients with COVID-19 in need of an intensive care unit

enthalten in: Central-European journal of immunology | 2022

von Güven, B. | Özçelik, F. | Tanoglu, A.

4

Gamma-glutamyl-transferase may predict COVID-19 outcomes in hospitalised patients

enthalten in: International journal of clinical practice | 2021

von Kasapoglu, B. | Yozgat, A. | Tanoglu, A. | +3

5

Assessment of severity and mortality of COVID-19 with anti-A1 and anti-B IgM isohaemagglutinins, a reflection of the innate immune status

enthalten in: International journal of clinical practice | 2021

von Ozcelik, F. | Tanoglu, A. | Guven, B. | +2

6

Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19

enthalten in: Turkish journal of medical sciences | 2021

von Yozgat, A. | Kasapoğlu, B. | Can, G. | +9

7

Assessment of severity and mortality of COVID‐19 with anti‐A1 and anti‐B IgM isohaemagglutinins, a reflection of the innate immune status

enthalten in: International Journal of Clinical Practice | 2021

von Ozcelik, F. | Tanoglu, A. | Guven, B. | +2

8

Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content

enthalten in: Medical hypotheses | 2020

von Beyazit, F. | Beyazit, Y. | Tanoglu, A. | +1

1
[1]